Modulation of glucagon receptor expression

Details for Australian Patent Application No. 2006292217 (hide)

Owner Isis Pharmaceuticals, Inc.

Inventors Bhanot, Sanjay; Freier, Susan M.; Monia, Brett P.

Agent Shelston IP

Pub. Number AU-A-2006292217

PCT Pub. Number WO2007/035771

Priority 60/718,684 19.09.05 US

Filing date 19 September 2006

Wipo publication date 29 March 2007

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 31/712 (2006.01) - Nucleic acids or oligonucleotides having modified sugars, i.e. other than ribose or 2'-deoxyribose

Event Publications

17 April 2008 PCT application entered the National Phase

  PCT publication WO2007/035771 Priority application(s): WO2007/035771

14 January 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006292218-Orthopedic implant insertion handle and aiming guide

2006292212-Biomarker for prostate cancer